Skip to main content

Guardant Health, Inc. (GH) Stock

Guardant Health, Inc. Stock Details, Movements and Public Alerts

Stock Details

Guardant Health, Inc. (GH), a prominent company in the healthcare sector within the diagnostics & research industry, is based in United States and primarily trades on the NMS.Currently, the stock is trading at $162.00. Over the past 52 weeks, it has ranged between $40.35 and $176.58. This places the current price at 91.7% of its 52-week high and 301.5% above its 52-week low. Recent trading volume was recorded at 4,584,133. The 14-day Relative Strength Index (RSI) stands at 61.87, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $142.11 by 14.00%. Similarly, it is above its 200-day moving average of $107.31 by 50.96%. The MACD histogram is -1.16, indicating bearish momentum (MACD Line: 2.35, Signal Line: 3.51). There is currently 1 active alert set for GH by users.

52-Week Range

$176.58 - $40.35

-8.26% from high · +301.49% from low

Avg Daily Volume

2,217,689

20-day average

100-day avg: 2,445,633

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-340.76

EV/EBITDA

-51.65

EPS (TTM)

-$3.51

Price to Sales

18.37

Q:How is GH valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is GH's risk profile compared to the market?
Risk profile data is not available for this stock.

Performance & Growth

Profit Margin

-38.33%

Operating Margin

-38.54%

EBITDA

$-430,969,984

Return on Assets

-18.08%

Revenue Growth (YoY)

44.30%

Q:How profitable and efficient is GH's business model?
Guardant Health, Inc. achieves a profit margin of -38.33%, meaning it retains $-38.33 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -38.54% reveals how efficiently the company runs its core business operations before interest and taxes.
Q:What are GH's recent growth trends?
Guardant Health, Inc.'s revenue grew by 44.30% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. These growth metrics should be evaluated against Diagnostics & Research industry averages for proper context.

Company Size & Market

Market Cap

$21.7B

Revenue (TTM)

$1.18B

Revenue/Share (TTM)

$9.14

Shares Outstanding

134.20M

Book Value/Share

-$1.38

Asset Type

EQUITY

Q:What is GH's market capitalization and position?
Guardant Health, Inc. has a market capitalization of $21.7B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 134.20M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Diagnostics & Research industry, it competes with other firms in this sector.
Q:How does GH's price compare to its book value?
Guardant Health, Inc.'s book value per share is -$1.38, while the current stock price is $162.00, resulting in a price-to-book (P/B) ratio of -117.65. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$173.17

6.89% upside potential

Analyst Recommendations

Strong Buy

5

Buy

16

Hold

2

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for GH?
23 analysts cover GH with 91% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $173.17 implies 6.9% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on GH?
Current analyst recommendations:5 Strong Buy, 16 Buy, 2 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Aug 1, 2026, 02:21 AM

Technical Indicators

RSI (14-day)

61.87

Neutral

50-Day Moving Average

$142.11

14.00% above MA-50

200-Day Moving Average

$107.31

50.96% above MA-200

MACD Line

2.35

MACD Signal

3.51

MACD Histogram

-1.16

Bearish

Q:What does GH's RSI value tell investors?
The RSI (Relative Strength Index) for GH is currently 61.87, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret GH's MACD and moving average crossovers?
MACD analysis shows the MACD line at 2.35 below the signal line at 3.51, with histogram at -1.16. This bearish crossover indicates downward pressure. The wide histogram confirms strong momentum. The 50-day MA ($142.11) is above the 200-day MA ($107.31), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Aug 1, 2026, 12:33 AM

Active Alerts

Alert Condition
Earnings Announcement
Threshold
3 days
Created
Jan 20, 2026, 04:51 PM

Stay Ahead of the Market with Guardant Health, Inc. Alerts

Set up price alerts for Guardant Health, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.